59 phenotypes from 5 alleles in 11 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Traf3ip2adjm/Traf3ip2adjm A.KOR-Traf3ip2adjm	dermatitis	J:162859
	increased IgE level	J:162859
Traf3ip2adjm/Traf3ip2adjm AK.KOR-Traf3ip2adjm	dermatitis	J:162859
	increased IgE level	J:162859
Traf3ip2adjm/Traf3ip2adjm B6.KOR-Traf3ip2adjm	dermatitis	J:162859
	increased IgE level	J:162859
Traf3ip2adjm/Traf3ip2adjm C.KOR-Traf3ip2adjm	dermatitis	J:162859
	increased IgE level	J:162859
Traf3ip2adjm/Traf3ip2adjm KOR-Traf3ip2adjm	dermatitis	J:162859
	female infertility	J:162859
	increased IgE level	J:162859
	increased pruritus	J:162859
	premature death	J:162859
	thick epidermis	J:162859
Traf3ip2Gt(IST11484G7)Tigm/Traf3ip2Gt(IST11484G7)Tigm involves: C57BL/6N	normal immune system phenotype	J:177650
Traf3ip2tm1.1Lix/Traf3ip2tm1.1Lix B6.129-Traf3ip2tm1.1Lix	abnormal glomerular capillary morphology	J:187766
	abnormal renal glomerulus morphology	J:187766
	abnormal transitional stage B cell morphology	J:187766
	enlarged cervical lymph nodes	J:187766
	enlarged spleen	J:187766
	normal immune system phenotype	J:187766
	increased anti-chromatin antibody level	J:187766
	increased anti-double stranded DNA antibody level	J:187766
	increased anti-histone antibody level	J:187766
	increased anti-nuclear antigen antibody level	J:187766
	increased autoantibody level	J:187766
	increased B cell number	J:187766
	increased IgG1 level	J:187766
	increased IgG2c level	J:187766
	increased IgG level	J:187766
	increased immature B cell number	J:187766
	increased marginal zone B cell number	J:187766
	increased mesangial cell number	J:187766
	increased spleen weight	J:187766
	lymph node hyperplasia	J:187766
	spleen hyperplasia	J:187766
Traf3ip2tm1.1Lix/Traf3ip2tm1.1Lix C.129-Traf3ip2tm1.1Lix	abnormal exocrine gland morphology	J:138560
	blepharitis	J:138560
	dry eyes	J:138560
	enlarged submandibular lymph nodes	J:138560
	glomerulonephritis	J:138560
	increased autoantibody level	J:138560
	increased follicular B cell number	J:138560
	increased inflammatory response	J:138560
	increased marginal zone B cell number	J:138560
	increased submandibular gland size	J:138560
	increased transitional stage B cell number	J:138560
	kidney inflammation	J:138560
	lacrimal gland inflammation	J:138560
	parotid gland inflammation	J:138560
	premature death	J:138560
	renal glomerular immunoglobulin deposits	J:138560
	stomatitis	J:138560
	submandibular gland inflammation	J:138560
	xerostomia	J:138560
Traf3ip2tm1.1Lix/Traf3ip2tm1.1Lix involves: 129/Sv * BALB/c	abnormal immune system morphology	J:93923
	abnormal immune system physiology	J:93923
	abnormal spleen B cell corona morphology	J:93923
	enlarged lymph nodes	J:93923
	enlarged spleen	J:93923
	increased anti-double stranded DNA antibody level	J:93923
	increased anti-histone antibody level	J:93923
	increased anti-single stranded DNA antibody level	J:93923
	increased autoantibody level	J:93923
	increased B cell number	J:93923
	increased dendritic cell number	J:93923
	increased IgE level	J:93923
	increased IgG level	J:93923
	increased immunoglobulin level	J:93923
	increased inflammatory response	J:93923
	lymphoid hyperplasia	J:93923
	respiratory system inflammation	J:93923
Traf3ip2tm1Lix/Traf3ip2tm1.1Lix Tg(CD19-cre/ERT2)1Cgn/0 involves: 129/Sv * BALB/c	enlarged lymph nodes	J:93923
	enlarged spleen	J:93923
	increased B cell number	J:93923
	increased dendritic cell number	J:93923
	increased immunoglobulin level	J:93923
Traf3ip2tm1Sbn/Traf3ip2tm1Sbn either: B6.129-Traf3ip2tm1Sbn or (involves: 129) or (involves: 129 * BALB/c)	abnormal cytokine secretion	J:144320
	decreased interleukin-6 secretion	J:144320
	decreased susceptibility to autoimmune disorder	J:144320
	impaired eosinophil recruitment	J:144320
	impaired macrophage chemotaxis	J:144320
	impaired neutrophil recruitment	J:144320
Traf3ip2tm1Sbn/Traf3ip2tm1Sbn involves: 129 * C57BL/6	decreased inflammatory response	J:191090